Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia caused by impaired insulin secretion, insulin action, or a combination of both. Over time, poor glycemic control can damage multiple organs and systems.
Common symptoms include:
If left uncontrolled, diabetes can lead to serious complications such as diabetic retinopathy, nephropathy, neuropathy, cardiovascular disease, and diabetic foot. These long-term risks significantly affect a patient's physical function, emotional well-being, and overall quality of life.
Stem cell therapy offers a new treatment option for both Type 1 and Type 2 diabetes by targeting the root causes of metabolic imbalance. At SunMoon, we emphasize responsible and science-driven medical care. Stem cell therapy is not a miracle cure, but a clinically supported approach that may help improve glycemic stability, reduce medication needs, and lower complication risks.
Stem cells promote the repair and regeneration of pancreatic islet β-cells, helping restore insulin-secreting capacity.
They enhance the responsiveness of muscle, liver, and adipose tissues to insulin, contributing to better glucose utilization.
By re-establishing immune tolerance and regulating the balance of pro- and anti-inflammatory cytokines, stem cells improve the inflammatory microenvironment within the islets.
They help coordinate digestive, endocrine, and circulatory system functions to rebalance metabolic homeostasis.
Stem cells induce VEGF secretion, promoting pancreatic angiogenesis and improving local blood supply and nutrient delivery.
Through paracrine effects, stem cells influence liver, gallbladder, pancreas, spleen, and kidney function—ultimately supporting long-term glycemic stability and complication prevention.
Deep Trust Built on Experience, Precision, and Long-Term Care
With more than a decade of clinical practice and over 1,200 diabetes stem cell cases, SunMoon has established a strong safety record. Our medical team accurately assesses risks, applies preventive strategies, and ensures safe, regulated treatment throughout the entire process.
Every patient undergoes multidimensional assessments, including metabolic profiling, immune status evaluation, and complication screening. Based on this, SunMoon creates a personalized treatment plan, integrating multiple delivery methods such as intravenous infusion, arterial intervention, acupoint injection, and targeted administration.
Diabetes requires long-term management. Beyond treatment, SunMoon provides personalized medical-wellness programs combining evidence-based pharmacological therapy, lifestyle guidance, and traditional Chinese medicine approaches. This integrated model helps maintain stable blood glucose levels and reduce the long-term risk of complications.
| Category | Clinical Metrics | Results |
|---|---|---|
| Clinical Volume | Total treated diabetes patients | 1,200+ cases |
| Type 2 diabetes | 700+ cases | |
| Type 1 diabetes | 500+ cases | |
| Type 2 Diabetes Outcomes | Glycemic improvement (HbA1c) | 90% achieved ≥1.5% reduction |
| Fasting glucose fluctuation | Reduced by 30%–50% | |
| Reduction in insulin use | 70% reduced dosage by 50% | |
| Medication-free glucose control (≥12 months) | 10% achieved | |
| Retinopathy symptom relief | 65% improved | |
| Peripheral neuropathy relief | 75% improved | |
| Type 1 Diabetes Outcomes | Glycemic variability (GV) | ↓ 40% |
| Daily insulin requirement | ↓ 30%–50% | |
| Severe hypoglycemia episodes | ↓ 70% | |
| Incidence of DKA | ↓ 80% | |
| Physical activity tolerance | Improved | |
| Anxiety & depression scores | ↓ 25% | |
| Health Dimension | Improvement Indicators | Observed Benefits |
|---|---|---|
| Glycemic Stability | Overall fasting glucose pattern | More stable glucose curve |
| HbA1c | ≥1.0% reduction | |
| Hypoglycemia frequency | 50%+ reduction | |
| Insulin Dependence | Exogenous insulin dosage | Reduced by 30%–60% |
| Complication Prevention | Retinopathy progression | Risk ↓ 40% |
| Renal microalbuminuria | ↓ 30% | |
| Neuropathic pain (VAS) | ↓ 3 points | |
| Diabetic foot ulcer healing | Time shortened by 80% | |
| Metabolic Improvement | BMI | Reduced |
| Lipid profile | Normalized | |
| Quality of Life | Energy, stamina, mobility | Markedly improved |
A Seamless, Professional, and Caring Treatment Journey
Online & multilingual consultation services — understand your condition, treatment options, and expected outcomes before arrival.
Visa guidance, itinerary planning, airport pickup, and hospital admission support — ensuring a smooth and worry-free journey to treatment.
Comprehensive health check, expert consultation, and AI-assisted analysis to design a precise, individualized stem cell therapy plan.
Cutting-edge stem cell transplantation combined with modern rehabilitation and traditional Chinese therapies to maximize recovery outcomes.
Remote follow-up, digital health tracking, and long-term recovery guidance through SunMoon's Personal Health Digital Twin Platform.
At SunMoon, science can restore hope — from consultation to recovery, we're with you every step of the way.
Yes. When performed in a regulated medical environment, stem cell therapy is generally safe. SunMoon applies strict protocols and continuous monitoring to minimize risks.
Improvements typically appear within 1–3 months, with metabolic benefits strengthening over 6 months or longer.
Some patients reduce medication needs, but no one should discontinue medication without medical supervision. All dosage changes must be guided by a specialist.
This depends on the treatment plan. Most patients require short-term observation after infusion, followed by scheduled follow-ups.
Mild fatigue or temporary glucose fluctuations may occur. Our medical team monitors every patient closely to manage potential reactions early.
Suitability must be evaluated by a pediatric endocrinologist and stem cell specialist. Safety and long-term outcomes will be considered carefully.
Duration varies by individual. Proper lifestyle management and follow-up care can significantly extend long-term benefits.